Company Intelligence

Trident Bioscience

Trident Bioscience builds tools to expedite the discovery and optimization of useful proteins. Our technology first applies predictive models of protein structure and function to generate sets of potentially active protein sequences. We then apply our…

In this profile

Quick Facts

  • Founded 2020
  • Headquarters San Francisco, USA; Remote
  • Country USA; Remote
  • Industry AI in Healthcare
  • Company Type Early
  • Status Inactive
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Trident Bioscience builds tools to expedite the discovery and optimization of useful proteins. Our technology first applies predictive models of protein structure and function to generate sets of potentially active protein sequences. We then apply our state-of-the-art sequence optimization algorithm to design gene libraries capable of testing these candidates extremely quickly and affordably. By combining these technologies, we're closing the design-build-test loop of protein optimization and cutting the total cycle time to help bring synthetic proteins to market faster than ever before.

Why It Matters

Accelerating protein engineering.

Recent Developments

  1. 2020 Company founded

    Trident Bioscience was founded in 2020 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Trident Bioscience builds tools to expedite the discovery and optimization of useful proteins. Our technology first applies predictive models of protein structure and function to generate sets of potentially active protein sequences. We then apply our state-of-the-art sequence optimization algorithm to design gene libraries capable of testing these candidates extremely quickly and affordably. By combining these technologies, we’re closing the design-build-test loop of protein optimization and cutting the total cycle time to help bring synthetic proteins to market faster than ever before.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe